Deal Announcements

BioLeap Jumps With $5 Million Series A Venture Funding

Thursday, January 14, 2010 5:53:00 AM PDT | VentureDeal Staff

New Hope, Pennsylvania  --  Biotechnology development company BioLeap has raised $5 million in its first round of institutional venture capital financing.

BioLeap has developed its own technology platform to "identify and optimize lead compounds where other approaches have not been successful."

Investors in the round were Adams Capital Management and Quaker BioVentures.  The company said it would use the funding to continue development of its computational fragment-based drug design technology and for business development.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1